Find Academic Supervisors

Thomas LavstsenView profile

Professor

• Malaria
• Host-pathogen interactions
• Molecular Biology
• +6 more

Thomas Lavstsen is a Professor in the Department of Immunology and Microbiology at the University of Copenhagen's Faculty of Health and Medical Sciences. He leads the DISCOVERY team at the Center for Medical Parasitology (CMP), focusing on molecular aspects of host-microbe interactions during human malaria infection. His primary research areas include: Malaria pathogenesis and immunity Molecular characterization of host-parasite interactions mediated by PfEMP1 proteins Vaccine development against malaria based on PfEMP1 Adjunct therapies to alleviate severe malaria symptoms Molecular evolution of Plasmodium falciparum Structural biology of parasite adhesion proteins Antibody responses to malaria infection Lavstsen's research has significantly advanced our understanding of how Plasmodium falciparum uses PfEMP1 proteins to bind to human receptors, particularly the endothelial protein C receptor (EPCR), which is linked to severe malaria in children. His work has shown that specific subsets of PfEMP1 proteins confer different endothelial receptor binding phenotypes and cause different severe malaria syndromes. This discovery has opened new avenues for vaccine development and understanding malaria immunity. His recent publications demonstrate a strong focus on malaria epidemiology, antibody responses, gene expression analysis, and computational approaches to understanding parasite biology. The research spans from basic molecular mechanisms to clinical applications and public health interventions, with particular emphasis on how parasites evade immune responses while maintaining critical binding functions. Lavstsen has received recognition through numerous citations and media attention for his work, with research featured in major news outlets and discussed on social media platforms including X, Bluesky, and Facebook. His research has been picked up by at least 12 news outlets and shared by numerous researchers on academic platforms. He actively collaborates with researchers across multiple countries, particularly in malaria-endemic regions of Africa, to understand the epidemiology and pathogenesis of malaria in real-world settings. His laboratory employs a multidisciplinary approach combining molecular biology, structural biology, bioinformatics, and clinical research to tackle the complex challenges of malaria pathogenesis.

Søren BakView profile

Professor

• Plant Biochemistry
• Molecular Evolution
• Specialized Metabolism
• +7 more

Søren Bak is a Professor in the Department of Plant and Environmental Sciences at the University of Copenhagen's Faculty of Science. He leads the Molecular Evolution Research Group and serves as the Section Leader for Plant Biochemistry. His academic journey began with a Cand. scient. from the University of Copenhagen in 1993, followed by a PhD from KVL (now part of the University of Copenhagen) in 1997. After serving as a Visiting Scientist at the University of Arizona (1998-2000), he progressed from Assistant to Associate Professor at KVL (2000-2005) before becoming a Professor at the University of Copenhagen. His research focuses on plant specialized metabolism, particularly the molecular evolution of biochemical innovations in plants. Key research areas include: Plant defense mechanisms and specialized compounds Saponins as potential bio-pesticides for sustainable agriculture (EcoSap project) Environmental impact of plant metabolites (SapFate project) Integration of biotechnology with anthropology and law for sustainable agriculture (BioPlantPro project) Metabolomics and molecular evolution of plant specialized metabolism Analysis of his recent publications reveals a strong focus on plant specialized metabolism, particularly saponins and other defense compounds. His work bridges fundamental biochemistry with practical applications in sustainable agriculture and biotechnology. The research spans from molecular-level investigations of enzyme function and metabolic pathways to broader ecological and environmental implications. As an academic leader, he has served as Studyleader for the BSc Biotechnology education (2008-2012) and Head of the Plant Biochemistry section (2015-2023). He currently chairs the Natural Sciences council of the Independent Research Fund Denmark (2024), having served as Vice Chairman (2023) and council member (2019-2024). His teaching portfolio includes courses in bioinformatics and advanced plant biology, reflecting his interdisciplinary approach that combines classical biochemistry with modern omics technologies and computational methods.

Maren SchrölkampView profile

Researcher

• Molecular Cardiology
• Membrane Proteins
• Cardiovascular Genetics
• +4 more

Maren Schrölkamp is an Academic employee with an MSc in Biochemistry at the Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen. She is affiliated with the Molecular Cardiology and Membrane Proteins research group and maintains an active research profile with publications in high-impact journals such as Nature Communications, European Heart Journal, and Frontiers in Cell and Developmental Biology. Her ORCID profile (0000-0003-3522-6379) documents her scholarly contributions to biomedical research. Her research interests span multiple interconnected domains in biomedical sciences, with primary focus on Molecular Cardiology and Membrane Proteins . Her work explores cardiovascular genetics, proteomics of cardiac tissues, adipose stem cell biology in obesity, and epigenetic mechanisms in metabolic disorders. She has contributed to understanding the molecular basis of conditions including mitral valve prolapse, diabetes in pregnancy, and narcolepsy. Her research methodology frequently employs advanced techniques such as quantitative proteomics, transcriptomics, and genome-wide association studies. Analysis of her seven recent publications reveals a strong emphasis on molecular mechanisms underlying cardiovascular diseases, with growing interest in genetic and epigenetic factors. Her work shows increasing collaboration with international research teams, particularly evident in her 2022 European Heart Journal publication with 34 additional authors. The research spans basic science investigations of cellular mechanisms to clinical applications in cardiovascular genetics and metabolic disorders. Maren Schrölkamp has no publicly listed scientific awards in the provided information. Her research has been disseminated through multiple peer-reviewed publications with significant citation impact, including 84 citations for her Nature Communications paper on cardiac pacemaking mechanisms. While specific grant information is not provided in the text, her collaborative publications suggest participation in multi-institutional research projects. The diversity of her research topics indicates involvement in multiple research initiatives across cardiovascular biology, metabolic disorders, and sleep medicine. She is actively affiliated with the Molecular Cardiology and Membrane Proteins research group at the University of Copenhagen's Department of Biomedical Sciences. This research environment focuses on understanding the molecular mechanisms of cardiovascular function and disease, utilizing advanced proteomic and genomic techniques to investigate cardiac biology at the cellular and molecular levels.

• Plant Biochemistry
• Plant Genomics
• Systems Biology
• +4 more

Marek Mutwil serves as an Associate Professor in the Department of Plant and Environmental Sciences at the University of Copenhagen, specializing in plant biochemistry with research spanning genomics, systems biology, and computational approaches to plant science. His work bridges experimental biology and data-intensive methodologies to address fundamental questions in plant environmental responses. His research program focuses on deciphering regulatory networks in plant stress adaptation, particularly through cross-species analyses of abiotic stress mechanisms in hydroponic systems. A significant portion of his recent work involves developing computational infrastructure for plant science, exemplified by the PlantConnectome knowledge graph that integrates literature-derived biological relationships across 71,000+ plant research articles. This dual emphasis on experimental stress physiology and bioinformatics resource development positions his work at the intersection of molecular plant biology and data science. Analysis of his 2025 publications reveals a consistent trajectory toward integrative plant systems biology, combining hydroponic crop stress experiments with large-scale knowledge graph applications. These works demonstrate growing emphasis on translational bioinformatics tools that convert fragmented plant science literature into structured, queryable biological networks. Scientific Awards: No awards were documented in the provided text. Advising and Grants: The source material contains no references to graduate students, postdoctoral trainees, or research funding sources. Labs and Teams: While affiliated with the Section for Plant Biochemistry, no specific laboratory structure, team members, or collaborative consortia are described in the available information.

• Stem Cell Biology
• Intestinal Development
• Organoid Technology
• +3 more

Martti Maimets serves as an Associate Professor in the Department of Biomedical Sciences at the University of Copenhagen's Faculty of Health and Medical Sciences. He is affiliated with reNEW (a stem cell research center) and the Jensen Lab, focusing on intestinal biology and stem cell research. His work bridges basic science with clinical applications in gastrointestinal diseases. His research interests center on intestinal stem cell biology, organoid technology, and signaling pathways including Wnt, Shh, and JAK/STAT. These areas are critical for understanding intestinal development, homeostasis, and disease mechanisms, particularly in inflammatory bowel diseases like ulcerative colitis. His laboratory employs advanced techniques including fate mapping, transcriptional profiling, and proteomics to investigate cellular differentiation and tissue regeneration. Maimets' recent publications demonstrate a strong focus on how signaling pathways regulate intestinal epithelium maturation and regionalization. His work with organoid models has provided insights into host-microbe interactions and disease mechanisms. The research shows a clear trajectory toward understanding the molecular basis of gastrointestinal diseases and developing potential therapeutic approaches. His scientific contributions include significant publications in high-impact journals such as Nature Communications, Cell Stem Cell, and Science Advances. His work on mesenchymal-epithelial crosstalk and YAP signaling has been particularly influential in the field of intestinal development. Maimets actively collaborates with researchers across multiple institutions, as evidenced by his co-authorship on numerous publications. His work with primary epithelial organoids represents an important methodological contribution to the field, allowing for more accurate modeling of human intestinal biology.

• Developmental Biology
• Stem Cell Research
• Single-Cell Genomics
• +2 more

Martin Proks is a Postdoctoral Research Fellow at the Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, affiliated with the reNEW research center. He conducts dual-lab research in the Sedzinski Lab (led by Jakub Sedzinski) and Brickman Lab (led by Josh Brickman), focusing on the molecular mechanisms of early embryonic development using integrated experimental and computational approaches. Dr. Proks holds a PhD and specializes in single-cell genomics and developmental biology. His research examines lineage specification in embryonic and extra-embryonic tissues, particularly endoderm differentiation, employing single-cell RNA sequencing and deep learning models to investigate transcription factor networks and cell fate decisions in mouse and human preimplantation embryos. His publication record (2022-2025) reveals consistent contributions to understanding primitive endoderm plasticity, transcriptional regulation of lineage priming, and computational tool development for single-cell data analysis. Key trends include the application of machine learning to embryonic models, identification of central intermediates in endoderm transitions, and development of bioinformatics pipelines like nf-core/marsseq, with work published in *Cell*, *Nature Methods*, and *Nature Cell Biology*. Scientific Awards: No awards or fellowships are documented in available sources. Advising and Grants: Information regarding student supervision or independent grant funding is not provided; as a postdoctoral researcher, he likely contributes to principal investigators' funded projects. Labs and Teams: Dr. Proks collaborates within two specialized research groups: the Sedzinski Lab investigates biomechanical aspects of tissue morphogenesis during embryogenesis, while the Brickman Lab focuses on stem cell pluripotency and signaling dynamics in early development. Both operate under reNEW's international framework for stem cell research, facilitating cross-disciplinary collaboration in developmental biology.

• Medical bioinformatics
• Inflammatory skin diseases
• Multidrug resistance in cancer
• +8 more

Thomas Litman is a Professor in the Department of Immunology and Microbiology at the University of Copenhagen's Faculty of Health and Medical Sciences, where he leads bioinformatics research at the Skin Immunology Research Center. With expertise spanning multiple omics technologies, he applies computational approaches to understand complex biological systems, particularly in the context of inflammatory skin diseases and cancer biology. Dr. Litman earned his PhD from the University of Copenhagen in 1996 with research focused on 'The multidrug resistant phenotype - a comparative study.' His academic journey has positioned him at the intersection of computational biology and medical research. Professor Litman's research centers on medical bioinformatics, with particular emphasis on inflammatory skin diseases including atopic dermatitis, psoriasis, and cutaneous T-cell lymphoma. He investigates multidrug resistance in cancer, utilizing transcriptomics, metabolomics, microbiome analysis, and proteomics to develop integrated 'skinomics' approaches. His work focuses on identifying molecular biomarkers with diagnostic, prognostic, and predictive value, especially for characterizing endotypes of inflammatory skin conditions. Through structural bioinformatics and translational research using cellular models, 3-D models, and clinical data, he bridges computational analysis with real-world medical applications. His recent publication record demonstrates a strong focus on applying multi-omics approaches to dermatological conditions, with significant contributions to understanding chronic hand eczema, basal cell carcinoma, and cutaneous T-cell lymphoma. His work increasingly integrates clinical data with molecular profiling to identify biomarkers and therapeutic targets, reflecting a trend toward more personalized approaches in dermatology and oncology. Professor Litman actively supervises bachelor's, master's, and PhD students in applied bioinformatics, encouraging the next generation of researchers to explore the 'data jungle' through computational analysis. His research is supported by collaborations with LEO Pharma and other industry partners, facilitating translational research from bench to bedside.

• Cardiovascular Disease
• Pharmacogenetics
• Veterinary Pharmacology
• +3 more

Maria Josefine Reimann is a DVM and postdoctoral researcher at the Department of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen. She serves as a Lifepharm Guest Researcher in Preclinical Disease Biology and is part of The Graduate Programme for In Vivo Pharmacology and Experimental Animals. Her professional address is Ridebanevej 9, 1870 Frederiksberg C, Denmark, with contact information including phone numbers +4535333179 and +4522461456, and email mreimann@sund.ku.dk. Dr. Reimann's research program centers on valvular heart disease in dogs, with specialized focus on myxomatous mitral valve disease (MMVD) in Cavalier King Charles Spaniels. She investigates the identification and physiological significance of genetic polymorphisms and their impact on response to medical treatment in canine cardiac conditions. Her work bridges veterinary clinical practice with molecular and pharmacological research, contributing to the understanding of disease mechanisms that have potential translational relevance to human cardiology. Analysis of her recent publications (2021-2024) reveals consistent research themes focusing on genetic factors in canine heart disease, platelet function in cardiac pharmacology, and metabolic aspects of heart failure. Her work demonstrates sophisticated integration of molecular biology techniques, clinical veterinary medicine, and pharmacological approaches to address complex questions in comparative cardiology, with particular attention to breed-specific manifestations of disease. Dr. Reimann has participated in numerous professional development activities including the European College of Veterinary Internal Medicine, American College of Veterinary Internal Medicine, SHARE symposium, and the FELASA C - Laboratory Animal Science Course where she served as a speaker. Her professional engagement also includes specialized workshops in statistics for veterinarians and the International Symposium on Regulatory Peptides, demonstrating breadth in her scientific interests.

• Cancer Genomics
• Genome Instability
• DNA Repair
• +7 more

Fran Supek is a Professor at the University of Copenhagen's Faculty of Health and Medical Sciences, where he leads the Genome Data Science laboratory at the Biotech Research & Innovation Centre (BRIC). He also maintains a research group at the IRB Barcelona. Supek is the Principal Investigator of ERC Starting and ERC Consolidator projects, an EMBO Young Investigator, and holds an ICREA tenured professor position (currently on leave). Dr. Supek obtained his PhD in Molecular Biology in 2010 from the University of Zagreb, followed by postdoctoral training at the Centre for Genomic Regulation (CRG) as a Marie Curie fellow. He established his independent laboratory at IRB Barcelona in 2017 as a "Ramón y Cajal" tenure-track fellow, and expanded to BRIC in 2024. His research focuses on statistical genomics and machine learning approaches to study genome stability mechanisms, particularly through analysis of mutation patterns in cancer. The Genome Data Science lab performs large-scale bioinformatic studies of multi-omic data from human tumors, populations, and metagenomes. Key research areas include DNA repair mechanisms, mRNA synthesis and turnover pathways, genetic interactions in cancer genomes, and machine learning approaches for inferring gene function from genomic data. Analysis of Supek's recent publications reveals a strong emphasis on cancer genomics, with particular focus on mutational signatures, DNA repair deficiencies, and the application of artificial intelligence to genomic data analysis. His work spans from fundamental mechanisms of genome instability to translational applications in cancer diagnosis and treatment. ERC Starting Grant recipient ERC Consolidator Grant recipient EMBO Young Investigator ICREA tenured professor (on leave) As Principal Investigator of multiple ERC projects, Supek leads a research program with significant funding for innovative genomic research. His laboratory at BRIC and IRB Barcelona conducts interdisciplinary research combining computational approaches with experimental validation to address fundamental questions in genome biology and cancer evolution. The Genome Data Science lab maintains active collaborations across multiple institutions, with research spanning statistical genomics, machine learning applications in bioinformatics, and experimental validation of computational predictions in cancer biology.

Nanna BjarnholtView profile

Associate Professor

• Plant Biochemistry
• Specialized Plant Metabolites
• Cyanogenic Glycosides
• +7 more

Nanna Bjarnholt is an Associate Professor in the Department of Plant and Environmental Sciences at the University of Copenhagen's Faculty of Science, where she leads the Plant Metabolic Plasticity Group. Her research focuses on plant specialized metabolites, particularly cyanogenic glycosides and glutathione transferase enzymes, using advanced mass spectrometry imaging and metabolomics techniques. Dr. Bjarnholt earned her MSc in Environmental Chemistry (2003) and PhD in Plant Biochemistry (2007), both from the University of Copenhagen. After completing postdoctoral work at the Department of Plant Biology and Biotechnology (2008-2014), she was appointed Associate Professor in 2014 and became a Research Group Leader in 2018. Her research primarily investigates the physiological roles and catabolism of cyanogenic glycosides in plants like sorghum, Lotus japonicus, cassava, barley, and almond. A significant discovery from her work revealed that glutathione transferase enzymes (GSTs) catalyze a reductive cleavage reaction in a pathway for nitrogen recovery from cyanogenic glucosides. With funding from the VILLUM Foundation, her group focuses on uncovering additional GST functions in plant specialized metabolism. She has pioneered the application of mass spectrometry imaging to visualize metabolite distribution and enzymatic conversion in plant tissues. Analysis of her recent publications shows a consistent focus on plant specialized metabolism, particularly cyanogenic compounds and glutathione transferases. Her work spans fundamental biochemistry to crop science applications, with increasing emphasis on mass spectrometry imaging techniques. Recent research has expanded to include Cannabis sativa metabolite distribution, sorghum transformation methods, and plant-pathogen interactions. Dr. Bjarnholt has secured significant research funding, including a VILLUM Young Investigator grant (10 million DKK), a Semper Ardens grant from The Carlsberg Foundation (19 million DKK), and multiple other competitive grants totaling over 40 million DKK. Her research has resulted in 61 publications with substantial citations and international recognition. She currently supervises 4 PhD students (with 6 completed) and 1 postdoc (with 2 past), teaching B.Sc. level courses in biochemistry, metabolomics, and Mass Spectrometry Imaging. Her international collaborations include researchers from Newcastle University, University of Illinois, University of Queensland, University of Lausanne, and others. Dr. Bjarnholt serves on the Copenhagen Plant Science Center scientific committee and the departmental research committee, demonstrating her leadership within the academic community.

• Evolutionary Biology
• Molecular Biology
• Host-Pathogen Interactions
• +5 more

Henrik Hjarvard de Fine Licht is an Associate Professor in the Section for Organismal Biology at the Department of Plant and Environmental Sciences, Faculty of Science, University of Copenhagen. His research focuses on the evolution and molecular mechanisms behind pathogenic host specificity, disease emergence following pathogenic host shifts, and parasitic control of host behavior, primarily using fungal interactions with insects and plants as model systems. Dr. de Fine Licht earned his B.Sc. in Biology from the University of Copenhagen in 2002, followed by an M.Sc. in Biology in 2006 with thesis titled "Symbiont transmission, specificity and its consequences in two species of fungus-growing termites." He completed his Ph.D. in Evolutionary Biology in 2009 with dissertation on "Substrate use and enzyme activity in fungus-growing ants." B.Sc. in Biology (2002), University of Copenhagen M.Sc. in Biology (2006), University of Copenhagen Ph.D. in Evolutionary Biology (2009), University of Copenhagen His research program examines how insect pathogenic fungi adapt to multiple or single host insects using experimental evolution, molecular biology, and bioinformatics techniques. Dr. de Fine Licht employs diverse methodologies including microscopy, in-situ hybridization, PCR and sequencing, and gene expression analysis to investigate host-pathogen co-evolution. His work bridges evolutionary theory with practical applications for understanding disease emergence and biological control mechanisms. Current projects include "From plants to animals - understanding inter-kingdom host-shifts of fungal pathogens" and "Elucidating the evolutionary consequences of cryptic genetic variation and phenotypic plasticity for fungal host-shifts." His recent publications demonstrate growing sophistication in genomic approaches to study host-pathogen interactions across multiple fungal systems. The research shows increasing integration of high-throughput sequencing data with experimental evolution approaches, revealing molecular mechanisms underlying host specificity and adaptation. His work spans fundamental evolutionary questions while maintaining relevance to practical concerns in disease management and biological control. Dr. de Fine Licht's scientific contributions have been recognized with numerous prestigious awards: Carlsberg Foundation Young Researcher Fellowship (DKK 4,000,000, 2020) Sapere Aude | DFF-Starting grant (DKK 5,900,000, 2018) Villum Young Investigator grant (DKK 3,900,000, 2014) Carlsberg foundation postdoctoral fellowship (DKK 1,109,642, 2012) First prize, post-doc. poster award from SMBE (2012) Dr. de Fine Licht actively mentors students and has supervised multiple M.Sc. projects on fungal-insect interactions. He serves as course responsible for "Big Data in Biotechnology" and teaches "Animal and plant diversity." His research is supported by significant grants totaling over DKK 14 million, including the Carlsberg Foundation Young Researcher Fellowship and Sapere Aude | DFF-Starting grant. He has organized Ph.D. courses and serves on the editorial board of Fungal Ecology while reviewing for numerous high-impact journals. He leads research within the Applied Evolutionary Ecology group at the University of Copenhagen, which focuses on co-evolution in mutualistic and parasitic interactions. His laboratory combines molecular genetic techniques with ecological and evolutionary approaches, featuring specialized equipment for fungal cultivation, molecular analysis, and behavioral assays with insect hosts. The research environment fosters international collaboration with institutions across Europe and the Americas.

• Non-protein coding RNAs (ncRNAs)
• RNA structure biology
• Next-generation sequencing
• +5 more

Ernst Stefan Seemann serves as an Associate Professor in the Department of Veterinary and Animal Sciences within the Faculty of Health and Medical Sciences at the University of Copenhagen. His research focuses on non-protein coding RNAs (ncRNAs) and RNA structure functionality, utilizing advanced methodologies including RNA structure modeling, prediction of RNA-RNA and protein-RNA binding, and analysis of next-generation sequencing data. His primary research interests encompass: Non-protein coding RNAs (ncRNAs) and RNA structure biology Next-generation sequencing and single-cell RNA-seq analysis Comparative genomics and prediction/annotation of ncRNAs Host-pathogen RNA interactions Stem cell models for neurodegenerative diseases Seemann is actively involved in multiple high-impact research initiatives including investigations of novel ncRNAs in bacteria (NextProd project), animal ncRNAs (FAANG consortium), host-virus RNA-RNA interactions with Assoc Prof Troels KH Scheel, single-cell RNA sequencing in neurogenesis studies with Assoc Prof Vanessa J Hall, and transcriptomics in stem cell models for neurodegenerative diseases (NeuroStem project). His publication record demonstrates strong interdisciplinary collaboration across computational biology, veterinary science, and medical research. His scientific contributions span environmental microbiology, gene therapy, neuroscience, and computational biology, with recent work focusing on CRISPR applications, CAR T-cell engineering, microglial metabolism in dementia, and metabolic engineering of bacterial systems. His research has been cited across multiple platforms including academic journals, Mendeley readership, Wikipedia, and news outlets.

• Stem Cell Biology
• Developmental Biology
• Embryonic Lineage Specification
• +4 more

Yan Fung Wong is a Guest Researcher at the Department of Biomedical Sciences, reNEW, and Brickman Lab at the University of Copenhagen's Faculty of Health and Medical Sciences. Wong's research is centered within the Stem Cell and Developmental Biology field, specifically focusing on early embryonic lineage specification. Wong's research interests span across stem cell biology, developmental biology, and epigenetics. Their work primarily investigates embryonic lineage specification , with particular focus on endoderm differentiation and organ development . A significant portion of their research explores how naïve human pluripotent stem cells can be directed to form extra-embryonic tissues, which has implications for understanding early human development and potential regenerative medicine applications. Wong has also conducted research in hematopoietic progenitor biology, specifically studying DNA methylation patterns in myelodysplastic syndrome. Wong's publication record demonstrates a clear trajectory in developmental biology research, with a notable shift toward stem cell-based models of embryonic development. Their recent work (2022-2023) focuses on the molecular mechanisms underlying endoderm specification and organ development, utilizing advanced techniques like single-cell transcriptomics. Earlier work (2014, 2019) shows expertise in both hematopoietic stem cell biology and the application of stem cell models to study embryonic development. The research consistently addresses fundamental questions about how cell fate decisions are made during early development. Wong works within the Stem Cell and Developmental Biology research group led by Professor Josh Brickman at the Novo Nordisk Foundation Center for Stem Cell Biology (DanStem) in Copenhagen. The lab specializes in studying early embryonic lineage specification using stem cell models to circumvent ethical and practical challenges associated with in vivo human embryonic research.

• Endocrinology
• Diabetes Research
• Gastroenterology
• +3 more

Filip Krag Knop serves as a Clinical Professor at the Department of Clinical Medicine within the Faculty of Health and Medical Sciences at the University of Copenhagen. He also holds an Affiliate Professor position in the same department. His institutional affiliations include Rigshospitalet (Blegdamsvej 3, 2200 Copenhagen N) and Herlev Hospital (Borgmester Ib Juuls Vej 1, 2730 Herlev). His research spans Endocrinology, Diabetes, Gastroenterology, and Metabolism , with significant focus on neurogastroenterology, pancreatic diseases, and metabolic disorders. Current investigations include bile acid metabolism, GLP-1/GIP hormone mechanisms, diabetic complications, and novel diabetes treatments like SGLT2 inhibitors and semaglutide. Analysis of his recent publications reveals strong emphasis on translational research connecting gastrointestinal physiology with metabolic diseases, particularly diabetes pathophysiology and treatment. His work frequently employs cohort studies, clinical trials, and molecular techniques to explore gut-pancreas-brain interactions in metabolic disorders. Dr. Knop maintains active collaborations across multiple institutions, with research outputs heavily cited in diabetes and endocrinology literature. His work has been featured in 27 news outlets and discussed across social media platforms including X (formerly Twitter), Facebook, and Reddit.

• Immunology
• Microbiology
• Bacteriology
• +5 more

Blaine Gabriel Fritz is an Assistant Professor and Postdoc in the Department of Immunology and Microbiology at the Faculty of Health and Medical Sciences, University of Copenhagen. His research focuses on the intersection of immunology, microbiology, and bacteriology, with particular emphasis on understanding host-microbe interactions in various disease contexts. Dr. Fritz's research interests span several key areas: Host immune responses to bacterial infections Microbiome dynamics in skin conditions like atopic dermatitis Biofilm formation and its implications in chronic infections and medical device complications Novel approaches to microbial sampling and analysis Pathogen-host interactions in cancer microenvironments His recent publications (2024-2025) demonstrate a strong focus on translational research bridging basic microbiological principles with clinical applications. His work spans diverse areas from atopic dermatitis and skin microbiome research to biofilm-related complications in cancer and medical implants. A significant portion of his research examines the role of bacterial communities in modulating immune responses across various disease states, with several publications receiving notable attention as evidenced by citation metrics. Dr. Fritz maintains active collaborations with researchers across multiple disciplines, particularly with Thomas Bjarnsholt and other colleagues at the University of Copenhagen, indicating an interdisciplinary research program with strong translational potential.